Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Cornerstone Planning Group »

Tvardi Therapeutics shares owned by Cornerstone Planning Group

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Cornerstone Planning Group from 13F filings

Historical chart of Cornerstone Planning Group investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Cornerstone Planning Group consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Cornerstone Planning Group

Quarter filed	Position value	Share count	Share price at filing
2025-12-31	$4	1	4.00

More positions owned by Cornerstone Planning Group

Invesco Nasdaq 100 Etf Exchange Traded Fund (QQQM)

Fidelity Enhanced International Etf Exchange Traded Fund (FENI)

Schwab Fundamental U.s. Large Company Etf Exchange Traded Fund (FNDX)

Vanguard Intermediate-term Bond Etf Exchange Traded Fund (BIV)

Ishares U.s. Smallcap Equity Factor Etf Exchange Traded Fund (SMLF)

Ishares Morningstar Mid-cap Growth Etf Exchange Traded Fund (IMCG)

Ishares Convertible Bond Etf Exchange Traded Fund (ICVT)

Invesco Qqq Trust Series I Exchange Traded Fund (QQQ)

Ishares High Yield Systematic Bond Etf Exchange Traded Fund (HYDB)

First Trust Long/short Equity Etf Exchange Traded Fund (FTLS)

Vanguard Ftse Developed Markets Etf Exchange Traded Fund (VEA)

Spdr S&p North American Natural Resources Etf Exchange Traded Fund (NANR)

Ishares Residential And Multisector Real Estate Etf Exchange Traded Fund (REZ)

Schwab Fundamental Emerging Markets Equity Etf Exchange Traded Fund (FNDE)

Victoryshares Short-term Bond Etf Exchange Traded Fund (USTB)

View all positions for Cornerstone Planning Group

Top funds holding Tvardi Therapeutics

Slate Path Capital

American Financial Group

Geode Capital Management

State Street Corporation

Renaissance Technologies

Duncan Williams Asset Management

Squarepoint Ops

Farallon Capital Management

Goldman Sachs Group

View all funds holding Tvardi Therapeutics

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z